NARA — Pangenomic Health Cashflow Statement
0.000.00%
Last trade - 00:00- CA$3.20m
- CA$3.81m
Annual cashflow statement for Pangenomic Health, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -0.003 | -0.14 | -2.65 | -12 |
| Depreciation | ||||
| Non-Cash Items | 0 | 0.003 | 1.83 | 8.98 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | -0.003 | 0.1 | -0.244 | 0.225 |
| Change in Accounts Receivable | ||||
| Change in Prepaid Expenses | ||||
| Change in Accounts Payable | ||||
| Change in Payable / Accrued Expenses | ||||
| Cash from Operating Activities | -0.007 | -0.038 | -1.06 | -2.78 |
| Capital Expenditures | — | 0 | -0.007 | -0.006 |
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | 0 | -0.1 | -0.598 | -0.046 |
| Acquisition of Business | ||||
| Sale of Business | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | 0 | -0.1 | -0.605 | -0.052 |
| Financing Cash Flow Items | 0 | 0.148 | 0 | — |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 0 | 0.173 | 2.97 | 1.57 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | -0.007 | 0.036 | 1.31 | -1.26 |